Back to search

Article

Biomarkers in Localized Prostate Cancer: Towards a Personalized Medicine

2025-06-20

Abstract excerpt

Prostate-specific antigen (PSA) has been the main biomarker used for the detection and monitoring of prostate cancer for decades. However, its limited specificity and prognostic accuracy have prompted the development of novel molecular and imaging biomarkers to improve the clinical characterization of localized disease. This review critically examines recent advances in urinary biomarkers (e.g., PCA3, SelectMDx),...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2266769c-f9fb-5c70-9ea4-3a18ccea363f
DOI
10.20944/preprints202506.1608.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Biomarkers in Localized Prostate Cancer: Towards a Personalized MedicineDOI 10.20944/preprints202506.1608.v1
Beyond blood biomarkers: the role of SelectMDX in clinically significant prostate cancer identificationSemantic proximity
Prostate cancer – a biomarker perspectiveSemantic proximity
Molecular diagnosis of prostate cancer: are we up to age?Semantic proximity
Usefulness of Tissue Biomarkers versus Prostate-Spcific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical ProstatectomySemantic proximity
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology AdvancementsSemantic proximity
PSA and beyond: the past, present, and future of investigative biomarkers for prostate cancer.Semantic proximity
Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?Semantic proximity
EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.Semantic proximity
Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer.Semantic proximity
Prostate Cancer: Genetics, Epigenetics and the Need for Immunological BiomarkersSemantic proximity
Prostate Cancer: Genetics, Epigenetics and the Need for Immunological BiomarkersSemantic proximity
Genomic analysis in active surveillance: predicting high-risk disease using tissue biomarkers.Semantic proximity
Select a neighboring publication to make it the new centre.